National Vision (EYE) chair sells 11,672 shares and exercises RSUs

Rhea-AI Filing Summary

National Vision Holdings Executive Chairman L. Reade Fahs reported multiple equity transactions involving restricted stock units and common stock. On March 6, 2026, one-third of a prior grant of 164,474 restricted stock units vested and 54,824 units were converted into common stock on a one-for-one basis.

Fahs received a further 71,685 restricted stock units as a new grant. To cover tax obligations from vesting, 24,419 common shares were disposed of at $27.90 per share by delivering shares. He also sold 7,601 common shares in open-market transactions at a weighted-average price of about $29.58 under a pre-established Rule 10b5-1 trading plan.

In addition, 4,071 common shares were sold at a weighted-average price of about $29.57 by a trust, noted as "Held by Trust." After these transactions, Fahs held 702,481 common shares directly and 359,359 common shares indirectly through the trust.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FAHS L READE

(Last) (First) (Middle)

C/O NATIONAL VISION HOLDINGS, INC.,

2435 COMMERCE AVENUE, BLDG. 2200

(Street)

DULUTH GA 30096-4980

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
National Vision Holdings, Inc. [ EYE ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Executive Chairman

3. Date of Earliest Transaction (Month/Day/Year)
03/06/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/06/2026		M		54,824	A	(1)	726,900	D
Common Stock	03/06/2026		F		24,419(2)	D	$27.9	702,481	D
Common Stock	03/06/2026		S		7,601(3)	D	$29.58(4)	694,880	D
Common Stock	03/06/2026		S		4,071(3)	D	$29.57(5)	359,359	I	Held by Trust

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	03/06/2026		M			54,824	(6)	(6)	Common Stock	54,824	$0	137,971	D
Restricted Stock Units	(1)	03/06/2026		A		71,685		(7)	(7)	Common Stock	71,685	$0	209,656	D

Explanation of Responses:

1. Each restricted stock unit converts into common stock on a one-for-one basis.

2. Reflects payment of tax liability by withholding securities incident to vesting of restricted stock units.

3. This sale was effected pursuant to a Rule 10b5-1 trading plan established by the reporting person on December 4, 2025.

4. Price represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $29.50 to $29.71. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.

5. Price represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $29.50 to $29.70. Upon request by the SEC staff, the issuer or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.

6. On March 7, 2025, the reporting person was granted 164,474 restricted stock units, vesting in three equal installments beginning on the first anniversary of the grant date.

7. One-third of these restricted stock units will vest on each anniversary of the grant date, March 6, 2026.

Remarks:

	/s/ Jared Brandman, as Attorney-in-Fact	03/09/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transactions did EYE Executive Chairman L. Reade Fahs report?

L. Reade Fahs reported vesting and conversion of restricted stock units, a new restricted stock unit grant, tax-related share withholding, and open-market stock sales, including sales by a trust associated with him, all dated March 6, 2026.

How many National Vision (EYE) shares did L. Reade Fahs sell on March 6, 2026?

He sold 7,601 common shares directly in open-market transactions and 4,071 common shares were sold by a trust, totaling 11,672 shares sold in the market, separate from 24,419 shares delivered to cover tax liabilities.

At what prices were L. Reade Fahs’ EYE shares sold according to the Form 4?

Direct open-market sales used a weighted-average price of about $29.58, with trades between $29.50 and $29.71. Trust sales used a weighted-average price near $29.57, with trades between $29.50 and $29.70, as disclosed in weighted-average footnotes.

What restricted stock unit activity did EYE’s Executive Chairman report?

One-third of a 164,474 restricted stock unit grant vested, resulting in 54,824 units converting one-for-one into common stock. Fahs also received a new award of 71,685 restricted stock units, adding to his equity-based compensation holdings at National Vision.

How many National Vision (EYE) shares does L. Reade Fahs own after these transactions?

Following the reported transactions, Fahs directly owned 702,481 shares of National Vision common stock and indirectly owned 359,359 shares held by a trust, as reflected in the post-transaction ownership figures on the Form 4.

Was L. Reade Fahs’ EYE stock sale under a Rule 10b5-1 trading plan?

Yes. A Form 4 footnote states the open-market sale was effected under a Rule 10b5-1 trading plan that Fahs established on December 4, 2025, indicating the sales followed a prearranged trading schedule.

Why were some EYE shares delivered for tax withholding in Fahs’ Form 4?

A footnote explains that 24,419 common shares were withheld to satisfy tax liabilities arising from the vesting of restricted stock units. Instead of paying cash, shares were delivered to cover the required tax obligation.